
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $1.9B | $2B | $1.9B | $2.1B | |
Revenue Growth (YoY) | 2.07% | 13.91% | 3.79% | -3.58% | 10.7% | |
Cost of Revenues | $738.1M | $830.3M | $945.8M | $935.7M | $996.8M | |
Gross Profit | $946M | $1.1B | $1B | $984.1M | $1.1B | |
Gross Profit Margin | 56.17% | 56.72% | 52.5% | 51.26% | 53.09% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $254.9M | $264.7M | $281.4M | $262.8M | $270.4M | |
Other Inc / (Exp) | $116.8M | $137.2M | $121M | $129.7M | $146.7M | |
Operating Expenses | $500.1M | $534.6M | $569.5M | $559.6M | $576.6M | |
Operating Income | $445.9M | $553.4M | $475.8M | $424.5M | $551.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $568.7M | $693.7M | $609.3M | $594.7M | $746.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $121.4M | $147.1M | $133.8M | $132.4M | $165.6M | |
Net Income to Company | $447.3M | $546.6M | $475.5M | $462.3M | $581.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $447.3M | $546.6M | $475.5M | $462.3M | $581.2M | |
Basic EPS (Cont. Ops) | $3.05 | $3.87 | $3.49 | $3.49 | $4.47 | |
Diluted EPS (Cont. Ops) | $3.00 | $3.81 | $3.46 | $3.46 | $4.41 | |
Weighted Average Basic Share | $146.7M | $141.2M | $136.1M | $132.6M | $130.1M | |
Weighted Average Diluted Share | $149M | $143.3M | $137.4M | $133.7M | $131.7M | |
EBITDA | $653.2M | $786.9M | $698M | $669.2M | $822.5M | |
EBIT | $569.3M | $694.2M | $610M | $595.2M | $747.3M | |
Revenue (Reported) | $1.7B | $1.9B | $2B | $1.9B | $2.1B | |
Operating Income (Reported) | $445.9M | $553.4M | $475.8M | $424.5M | $551.7M | |
Operating Income (Adjusted) | $569.3M | $694.2M | $610M | $595.2M | $747.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $455.7M | $581.4M | $469.1M | $511.6M | $551.3M | |
Revenue Growth (YoY) | 9.87% | 27.6% | -19.32% | 9.05% | 7.77% | |
Cost of Revenues | $193.1M | $221.2M | $228.1M | $248.2M | $247.4M | |
Gross Profit | $262.6M | $360.3M | $241M | $263.4M | $303.9M | |
Gross Profit Margin | 57.62% | 61.96% | 51.38% | 51.49% | 55.13% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $64.1M | $73.1M | $69.2M | $63M | $70.1M | |
Other Inc / (Exp) | $33.7M | $32M | $29.6M | $33.9M | $29.2M | |
Operating Expenses | $129.7M | $145.5M | $139.3M | $137.6M | $146.9M | |
Operating Income | $132.8M | $214.8M | $101.8M | $125.9M | $157.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $167.3M | $247.4M | $140M | $170.4M | $196.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $37.9M | $57.1M | $33M | $39M | $44.9M | |
Net Income to Company | $129.5M | $190.3M | $107M | $131.4M | $151.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $129.5M | $190.3M | $107M | $131.4M | $151.5M | |
Basic EPS (Cont. Ops) | $0.90 | $1.38 | $0.80 | $1.00 | $1.20 | |
Diluted EPS (Cont. Ops) | $0.89 | $1.36 | $0.79 | $0.99 | $1.17 | |
Weighted Average Basic Share | $143.2M | $137.9M | $134M | $131.4M | $126.6M | |
Weighted Average Diluted Share | $145.3M | $139.7M | $135.3M | $132.7M | $129.5M | |
EBITDA | $190.1M | $272.6M | $158.1M | $189.3M | $215.2M | |
EBIT | $167.5M | $247.6M | $140.2M | $170.6M | $196.6M | |
Revenue (Reported) | $455.7M | $581.4M | $469.1M | $511.6M | $551.3M | |
Operating Income (Reported) | $132.8M | $214.8M | $101.8M | $125.9M | $157.1M | |
Operating Income (Adjusted) | $167.5M | $247.6M | $140.2M | $170.6M | $196.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $2B | $1.9B | $2B | $2.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $746.9M | $858.4M | $952.7M | $955.7M | $996.1M | |
Gross Profit | $978.1M | $1.2B | $926M | $1B | $1.2B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $258.8M | $273.6M | $277.5M | $256.6M | $277.5M | |
Other Inc / (Exp) | $124.6M | $135.5M | $118.6M | $134M | $142M | |
Operating Expenses | $509.6M | $550.4M | $563.3M | $557.9M | $585.9M | |
Operating Income | $468.5M | $635.3M | $362.7M | $448.6M | $583M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $596.8M | $773.7M | $501.9M | $625.1M | $772.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $129.3M | $166.3M | $109.8M | $138.4M | $171.4M | |
Net Income to Company | $467.5M | $607.4M | $392.2M | $486.6M | $601.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $467.5M | $607.4M | $392.2M | $486.6M | $601.3M | |
Basic EPS (Cont. Ops) | $3.22 | $4.34 | $2.91 | $3.68 | $4.67 | |
Diluted EPS (Cont. Ops) | $3.18 | $4.29 | $2.88 | $3.66 | $4.60 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $683.5M | $869.3M | $583.5M | $700.4M | $848.4M | |
EBIT | $597.4M | $774.4M | $502.6M | $625.6M | $773.3M | |
Revenue (Reported) | $1.7B | $2B | $1.9B | $2B | $2.2B | |
Operating Income (Reported) | $468.5M | $635.3M | $362.7M | $448.6M | $583M | |
Operating Income (Adjusted) | $597.4M | $774.4M | $502.6M | $625.6M | $773.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $455.7M | $581.4M | $469.1M | $511.6M | $551.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $193.1M | $221.2M | $228.1M | $248.2M | $247.4M | |
Gross Profit | $262.6M | $360.3M | $241M | $263.4M | $303.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $64.1M | $73.1M | $69.2M | $63M | $70.1M | |
Other Inc / (Exp) | $33.7M | $32M | $29.6M | $33.9M | $29.2M | |
Operating Expenses | $129.7M | $145.5M | $139.3M | $137.6M | $146.9M | |
Operating Income | $132.8M | $214.8M | $101.8M | $125.9M | $157.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $167.3M | $247.4M | $140M | $170.4M | $196.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $37.9M | $57.1M | $33M | $39M | $44.9M | |
Net Income to Company | $129.5M | $190.3M | $107M | $131.4M | $151.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $129.5M | $190.3M | $107M | $131.4M | $151.5M | |
Basic EPS (Cont. Ops) | $0.90 | $1.38 | $0.80 | $1.00 | $1.20 | |
Diluted EPS (Cont. Ops) | $0.89 | $1.36 | $0.79 | $0.99 | $1.17 | |
Weighted Average Basic Share | $143.2M | $137.9M | $134M | $131.4M | $126.6M | |
Weighted Average Diluted Share | $145.3M | $139.7M | $135.3M | $132.7M | $129.5M | |
EBITDA | $190.1M | $272.6M | $158.1M | $189.3M | $215.2M | |
EBIT | $167.5M | $247.6M | $140.2M | $170.6M | $196.6M | |
Revenue (Reported) | $455.7M | $581.4M | $469.1M | $511.6M | $551.3M | |
Operating Income (Reported) | $132.8M | $214.8M | $101.8M | $125.9M | $157.1M | |
Operating Income (Adjusted) | $167.5M | $247.6M | $140.2M | $170.6M | $196.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $784.6M | $831.4M | $853M | $834.7M | $839.9M | |
Short Term Investments | $34.1M | $28.3M | $32.1M | $31.3M | $29.6M | |
Accounts Receivable, Net | $154.4M | $170.2M | $172.7M | $171.2M | $197.7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $38.7M | $43.6M | $48.7M | $54.5M | $60.3M | |
Total Current Assets | $1.3B | $1.4B | $1.5B | $1.5B | $1.6B | |
Property Plant And Equipment | $227.4M | $212.5M | $206M | $193.8M | $188.5M | |
Long-Term Investments | $210M | $244.4M | $239.2M | $273.5M | $315.6M | |
Goodwill | $64.5M | $117.2M | $115.6M | $137.3M | $170.3M | |
Other Intangibles | $295.3M | $312.2M | $292.8M | $322.2M | $313.4M | |
Other Long-Term Assets | $32.3M | $24.9M | $33.7M | $37M | $47.2M | |
Total Assets | $2.2B | $2.4B | $2.4B | $2.5B | $2.7B | |
Accounts Payable | $7.8M | $10.3M | $13.3M | $10.6M | $13.1M | |
Accrued Expenses | $132.3M | $147M | $190.9M | $140.5M | $145.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $8.6M | $11.3M | $10.3M | $8.1M | $7.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $317.3M | $355.7M | $397.9M | $353M | $380.5M | |
Long-Term Debt | -- | $40M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $427.3M | $493.9M | $429.7M | $388.2M | $432.5M | |
Common Stock | $1.4M | $1.4M | $1.3M | $1.3M | $1.3M | |
Other Common Equity Adj | -$16.8M | -$19.8M | -$49M | -$37M | -$47M | |
Common Equity | $1.7B | $1.9B | $2B | $2.1B | $2.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.7B | $1.9B | $2B | $2.1B | $2.3B | |
Total Liabilities and Equity | $2.2B | $2.4B | $2.4B | $2.5B | $2.7B | |
Cash and Short Terms | $818.7M | $859.7M | $885.2M | $866M | $869.5M | |
Total Debt | -- | $40M | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $782.6M | $907.8M | $834.4M | $846.6M | $710.7M | |
Short Term Investments | $33M | $31.3M | $31.8M | $32M | $31.2M | |
Accounts Receivable, Net | $172.6M | $158.7M | $158.3M | $192.2M | $189M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $42.8M | $46.1M | $51M | $59.1M | $62.7M | |
Total Current Assets | $1.3B | $1.5B | $1.4B | $1.6B | $1.5B | |
Property Plant And Equipment | $222M | $211.5M | $207.2M | $188.9M | $184.5M | |
Long-Term Investments | $173.3M | $194.8M | $185.8M | $229.5M | $278.1M | |
Goodwill | $64.5M | $117.4M | $115.6M | $137.2M | $167.9M | |
Other Intangibles | $298.3M | $301.8M | $292.6M | $317.9M | $302.2M | |
Other Long-Term Assets | $31.7M | $27.6M | $38.3M | $54.7M | $52M | |
Total Assets | $2.2B | $2.4B | $2.3B | $2.6B | $2.6B | |
Accounts Payable | $5.5M | $8M | $14.2M | $10.3M | $11.2M | |
Accrued Expenses | $116.6M | $146M | $165.4M | $143.8M | $130.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $9.8M | $11.2M | $10.3M | $7.6M | $7.4M | |
Other Current Liabilities | -- | -- | -- | -- | $4.4M | |
Total Current Liabilities | $215.9M | $285.1M | $272.5M | $276M | $261.4M | |
Long-Term Debt | -- | $30M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $321.8M | $399.5M | $304.2M | $309.4M | $308.2M | |
Common Stock | $1.4M | $1.4M | $1.3M | $1.3M | $1.2M | |
Other Common Equity Adj | -$15.4M | -$28.2M | -$44.6M | -$41.3M | -$38.5M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.8B | $2B | $2B | $2.3B | $2.3B | |
Total Liabilities and Equity | $2.2B | $2.4B | $2.3B | $2.6B | $2.6B | |
Cash and Short Terms | $815.6M | $939.1M | $866.1M | $878.6M | $741.9M | |
Total Debt | -- | $30M | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $447.3M | $546.6M | $475.5M | $462.3M | $581.2M | |
Depreciation & Amoritzation | $83.9M | $92.6M | $87.9M | $74M | $75.2M | |
Stock-Based Compensation | $27M | $41.5M | $39.4M | $31.3M | $58.6M | |
Change in Accounts Receivable | -$45.9M | -$57.7M | -$18.6M | -$37.5M | -$64.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $488.7M | $633.1M | $566.1M | $447M | $622.3M | |
Capital Expenditures | $78.6M | $52.5M | $74.5M | $58.8M | $56.6M | |
Cash Acquisitions | -- | -$80.2M | -- | -$56.4M | -$38.5M | |
Cash From Investing | -$67.5M | -$164.9M | -$89.8M | -$141.5M | -$117.3M | |
Dividends Paid (Ex Special Dividend) | -$103.9M | -$105.5M | -$109.8M | -$114.8M | -$120.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $40M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$40M | -- | -- | |
Repurchase of Common Stock | -$427M | -$408.1M | -$344.7M | -$308.9M | -$500.1M | |
Other Financing Activities | -$633K | -$4M | -$868K | -$8.8M | -- | |
Cash From Financing | -$482.1M | -$422.3M | -$437.2M | -$331.3M | -$494.4M | |
Beginning Cash (CF) | $844.5M | $787.7M | $831.8M | $853.4M | $835M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$60.9M | $45.9M | $39.1M | -$25.8M | $10.6M | |
Ending Cash (CF) | $787.7M | $831.8M | $853.4M | $835M | $840.2M | |
Levered Free Cash Flow | $410.1M | $580.6M | $491.6M | $388.2M | $565.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $133.8M | $111.3M | $118.9M | $139.1M | -- | |
Depreciation & Amoritzation | $23.1M | $24.8M | $18.4M | $18.9M | -- | |
Stock-Based Compensation | $10.1M | $10M | $7.4M | $12.5M | -- | |
Change in Accounts Receivable | -$3.3M | -$26.8M | -$64.1M | -$21M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $188.4M | $70.2M | $68.1M | $114.7M | -- | |
Capital Expenditures | $17.2M | $17.8M | $14.8M | $14.1M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$25.4M | -$10.8M | -$8.8M | -$23.4M | -- | |
Dividends Paid (Ex Special Dividend) | -$52.4M | -$54.3M | -$57M | -$60M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$30M | -- | -- | -- | |
Repurchase of Common Stock | -$126.1M | -$110.2M | -$75M | -$116.9M | -- | |
Other Financing Activities | -$3.3M | -- | -- | -- | -- | |
Cash From Financing | -$168.4M | -$185.5M | -$120.9M | -$167.5M | -- | |
Beginning Cash (CF) | $785.7M | $908.2M | $834.7M | $846.9M | -- | |
Foreign Exchange Rate Adjustment | $1M | -$10.1M | $4.3M | -$2.1M | -- | |
Additions / Reductions | -$5.4M | -$126.1M | -$61.6M | -$76.2M | -- | |
Ending Cash (CF) | $781.3M | $772M | $777.4M | $768.6M | -- | |
Levered Free Cash Flow | $171.3M | $52.4M | $53.3M | $100.6M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $467.5M | $607.4M | $392.2M | $486.6M | $601.3M | |
Depreciation & Amoritzation | $86M | $95M | $80.9M | $74.8M | $75.1M | |
Stock-Based Compensation | $29.8M | $42.3M | $36.9M | $34.3M | $61.7M | |
Change in Accounts Receivable | -$54.6M | -$28.2M | -$18.8M | -$102.9M | -$43M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $526.3M | $757M | $420.1M | $445M | $656.5M | |
Capital Expenditures | $62M | $57.8M | $78.3M | $58.5M | $53.2M | |
Cash Acquisitions | -- | -- | -- | -- | -$39.1M | |
Cash From Investing | -$80.8M | -$166M | -$75M | -$162.2M | -$118M | |
Dividends Paid (Ex Special Dividend) | -$104.6M | -$107.9M | -$112.2M | -$117.4M | -$122.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$10M | -- | -- | -- | |
Repurchase of Common Stock | -$367.6M | -$437M | -$325.8M | -$274.5M | -$657M | |
Other Financing Activities | -$702K | -$4.1M | -$904K | -- | -- | |
Cash From Financing | -$426.6M | -$459.5M | -$409.2M | -$274.9M | -$673.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $18.9M | $131.5M | -$64.2M | $7.9M | -$135.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $464.3M | $699.1M | $341.8M | $386.5M | $603.3M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $263.2M | $301.6M | $225.9M | $270.5M | $151.5M | |
Depreciation & Amoritzation | $45.8M | $49.8M | $36.4M | $37.6M | $18.6M | |
Stock-Based Compensation | $19.9M | $20.6M | $15.5M | $23.5M | $14.1M | |
Change in Accounts Receivable | -$27.3M | -$21.4M | -$58.8M | -$81.1M | -$38.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $325M | $330.6M | $182.5M | $227M | $146.5M | |
Capital Expenditures | $27.7M | $33.6M | $34.5M | $33.5M | $16M | |
Cash Acquisitions | -- | -- | -- | -- | -$566K | |
Cash From Investing | -$56.1M | -$42.5M | -$25.8M | -$61.1M | -$38.4M | |
Dividends Paid (Ex Special Dividend) | -$105.5M | -$109.8M | -$114.8M | -$120.3M | -$62.3M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$40M | -- | -- | -- | |
Repurchase of Common Stock | -$197.3M | -$210.3M | -$156.2M | -$163.8M | -$203.7M | |
Other Financing Activities | -$4M | -$868K | -$904K | -- | -- | |
Cash From Financing | -$277.9M | -$332.2M | -$239.5M | -$229.7M | -$241.5M | |
Beginning Cash (CF) | $1.6B | $1.7B | $1.7B | $1.7B | $840.2M | |
Foreign Exchange Rate Adjustment | $2.6M | -$15.7M | $6.8M | -$2.7M | $4.2M | |
Additions / Reductions | -$9M | -$44.1M | -$82.8M | -$63.7M | -$133.4M | |
Ending Cash (CF) | $1.6B | $1.7B | $1.6B | $1.6B | $711M | |
Levered Free Cash Flow | $297.3M | $297M | $147.9M | $193.6M | $130.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.